Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.
第一作者:
Takahiro,Takazono
第一单位:
Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University School of Medicine, Nagasaki, Japan. moju516@nagasaki-u.ac.jp.
作者:
医学主题词
投药, 口服(Administration, Oral);老年人(Aged);抗菌药(Anti-Bacterial Agents);克拉霉素(Clarithromycin);乙胺丁醇(Ethambutol);糖皮质激素类(Glucocorticoids);人类(Humans);男(雄)性(Male);分枝杆菌属(Mycobacterium);分枝杆菌感染(Mycobacterium Infections);多软骨炎, 复发性(Polychondritis, Relapsing);利福平(Rifampin);他罗利姆(Tacrolimus);治疗结果(Treatment Outcome);肿瘤坏死因子α(Tumor Necrosis Factor-alpha)
DOI
10.1186/1471-2334-14-114
PMID
24576098
发布时间
2021-10-21
- 浏览52
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



